Showing 781 - 800 of 856 results
Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.
Research could lead to better herbicides and infection treatments
The 3D structure of a fungal and plant enzyme solves 50-year-old mystery.
Reducing, reusing and recycling mining waste
Two approaches use existing low cost and low energy technologies to reuse stockpiled waste from mining operations - capturing carbon dioxide in the form of valuable carbonate minerals.
ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Cosmogenic nuclides help explain stone formation
China’s vertical sandstone pillars studied using nuclear techniques
Exploring the role of water in the complex energy landscape of proteins
Surfing at the atomic scale: ANSTO scientists confirm experimentally new fundamental law for liquids
The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.
Australian Synchrotron joins Monash and key institutions in $2.9 million new platform to support drug development
Monash University is partnering with the Australian Synchrotron and other key institutions to launch a $2.9 million national project – delivering a robotic laboratory capable of drastically speeding up the invention, trials and commercialisation of medicines by Australian researchers.
How to Access MX3
Indigenous knowledge linked to pollution data
Atmosphere scientists find link between indigenous weather knowledge and Sydney air pollution.
Nuclear techniques confirm unique biology of human eye lens
Join ANSTO for a sensational week of science fun online
Symposium on advanced therapy
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Minister announces new detector
Australian-first detector to accelerate cancer research unveiled.
TSPO: Ancient gene ignites potential for drug development
ANSTO provides groundwork for promising new nuclear medicine
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
ANSTO's innovative approach to treating cancer gets funding
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.